Study aims to test Alzheimer's imaging agent Amyvid

05/28/2013 | Plain Dealer (Cleveland), The

Researchers at University Hospitals Case Medical Center in Ohio are recruiting patients believed to have early-stage Alzheimer's disease for a study that will test the imaging agent Amyvid. The study will seek to determine whether the tracer can identify brain plaques when used with PET/MRI. Researchers said the study can contribute to the understanding of Alzheimer's. "If you can help to outline the cause, you can start to find the therapy," said Dr. James O'Donnell. "You need to understand it."

View Full Article in:

Plain Dealer (Cleveland), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA